Pathophysiology, epidemiology, classification and treatment options for polycystic liver diseases

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 19, Issue 35

Peer-Review Report of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Gastroenterol. Sep 21, 2013; 19(35): 5775-5786
Published online Sep 21, 2013. doi: 10.3748/wjg.v19.i35.5775

Table 2 Risk factors for liver-cyst growth in polycystic liver disease

Risk factors for liver-cyst growth in polycystic liver disease
Advancing patient age
Female gender
Estrogen exposure: multiple pregnancies, OCPs, estrogen replacement therapy
Severity of renal dysfunction and renal cyst volume

OCPs: Oral contraceptive pills.

Citation: Abu-Wasel B, Walsh C, Keough V, Molinari M. Pathophysiology, epidemiology, classification and treatment options for polycystic liver diseases. World J Gastroenterol 2013; 19(35): 5775-5786
URL: https://www.wjgnet.com/1007-9327/full/v19/i35/5775.htm
DOI: https://dx.doi.org/10.3748/wjg.v19.i35.5775

Abu-Wasel B, Walsh C, Keough V, Molinari M. Pathophysiology, epidemiology, classification and treatment options for polycystic liver diseases. World J Gastroenterol 2013; 19(35): 5775-5786 [PMID: 24124322 DOI: 10.3748/wjg.v19.i35.5775]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.